Structure–activity relationship and biological evaluation of berberine derivatives as PCSK9 down-regulating agents

Tian-Yun Fan,Yu-Xin Yang,Qing-Xuan Zeng,Xue-Lei Wang,Wei Wei,Xi-Xi Guo,Li-Ping Zhao,Dan-Qing Song,Yan-Xiang Wang,Li Wang,Bin Hong

DOI: https://doi.org/10.1016/j.bioorg.2021.104994

IF: 5.307

2021-08-01

Bioorganic Chemistry

Abstract:<p>Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secreted protein and its deficiency markedly enhanced the survival rate of patient with cardiovascular diseases (CVDs). Forty berberine (BBR) derivatives were synthesized and evaluated for their activities on down-regulating the transcription of PCSK9 in HepG2 cells, taking BBR as the lead. Structure–activity relationship (SAR) analysis revealed that 2,3-dimethoxy moiety might be beneficial for activity. Among them, <strong>9k</strong> displayed the most potent activity with IC₅₀ value of 9.5 ± 0.5 μM, better than that of BBR. Also, it significantly decreased PCSK9 protein level at cellular level, as well as in the liver and serum of mice <em>in vivo</em>. Furthermore, <strong>9k</strong> markedly increased LDLR expression and LDL-C clearance via down-regulating PCSK9 protein. The mechanism of action of <strong>9k</strong> is targeting HNF1α and/or Sp1 cluster modulation upstream of PCSK9, a different one from BBR. Therefore, <strong>9k</strong> might have the potential to be a novel PCSK9 transcriptional inhibitor for the treatment of atherosclerosis, worthy for further investigation.</p>

biochemistry & molecular biology,chemistry, organic